Xenetic Biosciences, Inc. (XBIO): Price and Financial Metrics
XBIO Price/Volume Stats
| Current price | $4.30 | 52-week high | $5.20 |
| Prev. close | $4.32 | 52-week low | $2.78 |
| Day low | $4.19 | Volume | 4,367 |
| Day high | $4.30 | Avg. volume | 7,776 |
| 50-day MA | $4.14 | Dividend yield | N/A |
| 200-day MA | $4.01 | Market Cap | 6.63M |
XBIO Stock Price Chart Interactive Chart >
Xenetic Biosciences, Inc. (XBIO) Company Bio
Xenetic Biosciences, Inc. operates as a biopharmaceutical company. The Company focuses on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens, as well as offers cell-based therapeutics targeting the B-cell receptor on the surface of malignant tumor cells. Xenetic Biosciences serves patients in the United States.
XBIO Price Returns
| 1-mo | 3.61% |
| 3-mo | 13.31% |
| 6-mo | 0.46% |
| 1-year | 31.50% |
| 3-year | -58.25% |
| 5-year | -72.44% |
| YTD | 7.77% |
| 2024 | 15.65% |
| 2023 | 21.01% |
| 2022 | -77.90% |
| 2021 | -36.76% |
| 2020 | 41.67% |
Loading social stream, please wait...